Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNSNASDAQ:AXGNNASDAQ:EYENASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAVANOS MEDICAL$12.38+2.2%$12.46$11.75▼$25.36$560.02M1.14378,145 shs523,938 shsAXGNAxoGen$10.15+3.7%$12.60$7.01▼$21.00$445.88M1.05481,949 shs621,200 shsEYENational Vision$23.09+1.8%$17.79$9.56▼$23.33$1.79B1.241.90 million shs2.35 million shsSKINBeauty Health$1.92-0.5%$1.40$0.78▼$2.24$243.17M1.17966,615 shs667,161 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAVANOS MEDICAL-0.45%-1.10%-1.83%-14.62%-38.19%AXGNAxoGen+0.62%+0.41%-11.56%-48.45%+39.86%EYENational Vision-0.83%+1.52%+20.37%+68.57%+74.54%SKINBeauty Health+19.88%+25.32%+19.88%+36.88%+7.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAVANOS MEDICAL1.5777 of 5 stars0.03.00.00.00.81.72.5AXGNAxoGen2.7314 of 5 stars3.52.00.00.02.62.50.6EYENational Vision3.1901 of 5 stars2.24.00.03.32.80.80.0SKINBeauty Health0.3088 of 5 stars0.80.00.00.02.03.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAVANOS MEDICAL 0.00N/AN/AN/AAXGNAxoGen 3.00Buy$22.20118.72% UpsideEYENational Vision 2.44Hold$18.67-19.16% DownsideSKINBeauty Health 1.67Reduce$1.42-26.22% DownsideCurrent Analyst Ratings BreakdownLatest SKIN, EYE, AXGN, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.005/19/2025EYENational VisionBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetMarket Perform ➝ Market Perform$13.00 ➝ $19.005/13/2025AXGNAxoGenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$26.00 ➝ $24.005/12/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.005/9/2025EYENational VisionThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.005/9/2025EYENational VisionCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$13.00 ➝ $21.005/8/2025EYENational VisionUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/8/2025EYENational VisionLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $20.005/8/2025EYENational VisionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.005/7/2025EYENational VisionBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderperform ➝ Buy5/5/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.50 ➝ $1.25(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAVANOS MEDICAL$687.80M0.83$12.13 per share1.02$18.03 per share0.69AXGNAxoGen$187.34M2.47N/AN/A$2.36 per share4.30EYENational Vision$1.82B1.00$1.66 per share13.87$10.37 per share2.23SKINBeauty Health$334.30M0.72$0.06 per share30.52$0.41 per share4.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAVANOS MEDICAL-$392.10M-$8.378.717.15N/A-55.80%6.26%4.63%7/30/2025 (Estimated)AXGNAxoGen-$9.96M-$0.150.00N/AN/A-3.68%-7.09%-3.67%8/6/2025 (Estimated)EYENational Vision-$28.50M-$0.3363.0385.523.33-1.40%3.44%1.40%8/6/2025 (Estimated)SKINBeauty Health-$29.10M-$0.410.00N/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)Latest SKIN, EYE, AXGN, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025SKINBeauty Health-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million5/7/2025Q1 2025EYENational Vision$0.32$0.34+$0.02$0.18$510.30 million$510.32 million5/6/2025Q1 2025AVNSAVANOS MEDICAL$0.19$0.26+$0.07$0.14$161.75 million$167.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAVANOS MEDICALN/AN/AN/AN/AN/AAXGNAxoGenN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAVANOS MEDICAL0.122.571.56AXGNAxoGen0.634.282.65EYENational Vision0.290.540.35SKINBeauty Health12.017.476.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAVANOS MEDICAL95.17%AXGNAxoGen80.29%EYENational VisionN/ASKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipAVNSAVANOS MEDICAL2.64%AXGNAxoGen2.78%EYENational Vision2.70%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAVANOS MEDICAL2,22746.24 million45.02 millionOptionableAXGNAxoGen45045.54 million44.28 millionOptionableEYENational Vision13,41179.05 million76.92 millionOptionableSKINBeauty Health1,030125.99 million74.34 millionOptionableSKIN, EYE, AXGN, and AVNS HeadlinesRecent News About These CompaniesThe Best Amazon Beauty Products For Summer, According To DermatologistsJune 24 at 5:24 PM | womenshealthmag.comPersonal Care Stocks Q1 In Review: BeautyHealth (NASDAQ:SKIN) Vs PeersJune 24 at 5:24 PM | msn.comSeasonal Beauty Swaps You Should Make for Supple, Hydrated Winter SkinJune 24 at 6:03 AM | msn.comThe ‘Carnivore-ification' of Beauty and WellnessJune 24 at 12:53 AM | msn.comDo Regular Facials Actually Improve Your Skin?June 23 at 7:51 PM | nytimes.comKids’ skin care TikToks are costly and counterproductive, study saysJune 23 at 7:51 PM | msn.comNot Your Mother's Powder Blush. How A Classic Got A Skin-Friendly Glow Up.June 23 at 7:51 PM | msn.comPeople Always Ask for My Skincare Routine—Here’s Everything I Use as a Beauty Editor in My 30sJune 23 at 7:51 PM | msn.comEXCLUSIVE: Sakara Enters Credo Beauty With New Gut and Skin Health Supplement, Doubling Down on Both Beauty and WellnessJune 23 at 7:51 PM | msn.comHypochlorous Acid: How Does It Benefit Your Skin Health?June 22 at 1:40 PM | onlymyhealth.comHidden danger behind 5 beauty habits destroying your faceJune 22 at 1:40 PM | rollingout.comShahnaz Husain reveals her top DIY beauty secrets and simple home remedies using affordable ingredientsJune 22 at 8:40 AM | msn.comHappy birthday Meryl Streep: Know her no 1 beauty secret for glowing skin at 76 that costs absolutely nothingJune 22 at 3:39 AM | msn.comBikini Line Wax: 7 Post-Care Tips For Smooth And Healthy SkinJune 22 at 3:39 AM | herzindagi.comHow skin care routines are secretly ruining sleep qualityJune 21 at 5:37 PM | rollingout.comI Tried the Dermatologist (And TikTok) Approved 'Skin Cycling' Method For 2 Weeks And My Skin Thanked MeJune 21 at 2:59 AM | marieclaire.co.ukThis ceramide secret transforms every skin typeJune 20, 2025 | rollingout.comWeather shift, skin shift: How to adjust your skincare routine from summer to monsoonJune 20, 2025 | msn.comAV Laboratories: A Luxury Skin-Care Brand Founded by Geneticists and Molecular BiologistsJune 20, 2025 | msn.comTikTok’s ‘Sephora kids’ are embracing expensive skin care – but these routines carry a risk, study findsJune 19, 2025 | theglobeandmail.comMillennium Management LLC Raises Stake in The Beauty Health Company (NASDAQ:SKIN)May 30, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeRobinhood Director Sells Millions, But HOOD Stock Eyes GainsBy Gabriel Osorio-Mazilli | June 19, 2025View Robinhood Director Sells Millions, But HOOD Stock Eyes GainsSarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesBy Leo Miller | June 18, 2025View Sarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesCrowdStrike Eyes Breakout as Cyber Threats Boost DemandBy Chris Markoch | June 24, 2025View CrowdStrike Eyes Breakout as Cyber Threats Boost DemandThredUp Stock Reverses on AI Buzz, Eyes Double-Digit GainsBy Thomas Hughes | May 28, 2025View ThredUp Stock Reverses on AI Buzz, Eyes Double-Digit GainsSKIN, EYE, AXGN, and AVNS Company DescriptionsAVANOS MEDICAL NYSE:AVNS$12.38 +0.27 (+2.19%) Closing price 03:59 PM EasternExtended Trading$12.38 +0.01 (+0.04%) As of 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.AxoGen NASDAQ:AXGN$10.15 +0.36 (+3.68%) Closing price 04:00 PM EasternExtended Trading$10.15 +0.00 (+0.05%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.National Vision NASDAQ:EYE$23.09 +0.40 (+1.76%) Closing price 04:00 PM EasternExtended Trading$22.57 -0.52 (-2.25%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Beauty Health NASDAQ:SKIN$1.92 -0.01 (-0.52%) Closing price 04:00 PM EasternExtended Trading$1.91 -0.01 (-0.52%) As of 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
